Search This Blog

Friday, June 27, 2025

Eyenovia 1st US Public Company to Launch Institutional Crypto Validator on Hyperliquid



Eyenovia (NASDAQ: EYEN), an ophthalmic technology company, has announced a partnership with Kinetiq to launch a co-branded Hyperliquid validator called 'Kinetiq x Hyperion'. This initiative follows Eyenovia's recent acquisition of 1,040,584.5 HYPE tokens, making it the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of the Hyperliquid protocol.

The validator will be supported by Pier Two, an institutional staking services provider with SOC 2 Type I and II certifications. This collaboration represents Eyenovia's strategic move into onchain engagement, aiming to contribute to network stability while creating potential value through ecosystem participation.



Eyenovia's partnership with Kinetiq creates a revenue-generating validator using their substantial HYPE token holdings, representing a strategic blockchain diversification.

Eyenovia's announcement represents a significant evolution in their business strategy, moving beyond their core ophthalmic technology focus into blockchain infrastructure. The company has acquired an impressive 1,040,584.5 HYPE tokens and is now deploying them through a co-branded validator called "Kinetiq x Hyperion" on the Hyperliquid protocol.

This move demonstrates Eyenovia's commitment to generate value from their cryptocurrency holdings rather than simply holding them as treasury assets. By staking their HYPE tokens through a validator, the company can potentially earn staking rewards while contributing to the security and operation of the Hyperliquid network.

The partnership structure is particularly noteworthy: Eyenovia provides the capital (HYPE tokens), Kinetiq brings protocol engineering expertise, and Pier Two delivers the technical infrastructure with institutional-grade security (SOC 2 Type I and II certifications). This three-party arrangement allows Eyenovia to participate in validator economics without needing to develop all technical capabilities in-house.

From an investor perspective, this creates a dual value proposition: Eyenovia now offers exposure both to their traditional ophthalmic business and to potential returns from active participation in the Hyperliquid ecosystem. The company is positioning itself as a "bridge between public markets and the onchain economy" - essentially providing traditional investors with regulated access to cryptocurrency infrastructure returns.

This validator launch signals Eyenovia's intent to actively engage with blockchain projects rather than simply holding digital assets passively, potentially creating new revenue streams tied to network participation rather than solely relying on token price appreciation.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.